AGATA: Value of contrast-enhanced ultrasound in adnexal torsion - AGATA

CHRU NANCY0 个研究点目标入组 30 人开始时间: 2020年5月25日最近更新: 2021年4月5日

适应症

试验速览

暂无简介。

•Age = 18 years
•Planned surgery for suspected adnexal torsion
•Being affiliated to the Social Security system or benefiting from such a system
•Have received full information about the organization of the study and have signed their informed consent
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 15
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 15

•Any medical condition that contraindicates the administration of SonoVue® , in particular :
•o Documented hypersensitivity to sulfur hexafluoride or any of the other components of SonoVue
•o Woman with acute coronary syndrome or unstable ischemic heart disease
•o Woman with acute endocarditis
•o Woman with prosthetic valves
•o Woman with acute systemic inflammatory disease and/or sepsis
•o Woman in a state of hypercoagulation and/or recent thromboembolic event
•o Woman with end-stage kidney or liver disease
•o Woman with right-left shunt, severe pulmonary arterial hypertension (pulmonary arterial pressure > 90 mmHg)
•o Woman with uncontrolled systemic hypertension
•o Woman with respiratory distress syndrome
•Persons referred in Articles L. 1121-5, L. 1121-7 and L1121-8 of French Public Health Code :
•o Pregnant woman, parturient or breastfeeding mother
•o Minor person (not emancipated)
•o Adult person under legal protection (guardianship, curatorship, legal safeguard)
•o Adult who is unable to give consent
•Persons who are deprived of their liberty by a judicial or administrative decision, persons under psychiatric care pursuant to articles L. 3212-1 and L. 3213-1

发起方